Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)
Clinical trial NCT01311505 · COMPLETED
Trial details
- NCT number
- NCT01311505
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2011-05-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.